Factors Contributing to the Preference of Korean Patients with Crohn's Disease When Selecting an Anti-Tumor Necrosis Factor Agent (CHOICE Study)
about
Physicians Should Provide Shared Decision-Making for Anti-TNF Therapy to Inflammatory Bowel Disease Patients.Prospective comparison of preference and efficacy of adalimumab and infliximab for treating ulcerative colitis naive to antitumor necrosis factor therapy.Patients' Preference for a Specific Anti-Tumor Necrosis Factor Agent: Korea versus Western.
P2860
Factors Contributing to the Preference of Korean Patients with Crohn's Disease When Selecting an Anti-Tumor Necrosis Factor Agent (CHOICE Study)
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Factors Contributing to the Pr ...... is Factor Agent (CHOICE Study)
@en
type
label
Factors Contributing to the Pr ...... is Factor Agent (CHOICE Study)
@en
prefLabel
Factors Contributing to the Pr ...... is Factor Agent (CHOICE Study)
@en
P2093
P2860
P356
P1433
P1476
Factors Contributing to the Pr ...... is Factor Agent (CHOICE Study)
@en
P2093
Byung Ik Jang
Chang Kyun Lee
Chang Soo Eun
Eun Soo Kim
Geom Seog Seo
Hyo Jong Kim
IBD Study Group of the Korean ...... he Intestinal Diseases (KASID)
Kang-Moon Lee
Kyeong Ok Kim
P2860
P304
P356
10.5009/GNL15126
P577
2015-09-09T00:00:00Z